2024 Summer Conference | C2 - Neural Antibodies: From Discovery to Clinical Testing

Date Friday 07/19/24

Time 10:25 AM - 11:25 AM EDT Add To Calendar

Location Hilton Atlanta | Salon

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Moderator(s) Angela Vincent, MBBS, MSc, Anastasia Zekeridou, MD, PhD, FAAN

Topic(s) Autoimmune Neurology

Learning Objectives Participants should become familiar with the techniques used to discover the antigenic targets of antibodies, how to validate them for clinical practice, and red flags for antibody testing and interpretation.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
10:25 AM - 10:55 AM EDT	Speaker	Antibody Discovery Principles and Methodologies Michael R. Wilson, MD, FAAN
10:55 AM - 11:25 AM EDT	Speaker	Antibody Validation, Clinical Utility, and Caveats: Are All Antibodies Useful? Andrew McKeon, MD

Faculty Disclosures
Angela Vincent, MBBS, MSc	Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care.
Anastasia Zekeridou, MD, PhD, FAAN	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Michael R. Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��